Linzhi Chen

690 total citations
33 papers, 352 citations indexed

About

Linzhi Chen is a scholar working on Molecular Biology, Immunology and Civil and Structural Engineering. According to data from OpenAlex, Linzhi Chen has authored 33 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Immunology and 6 papers in Civil and Structural Engineering. Recurrent topics in Linzhi Chen's work include Biosimilars and Bioanalytical Methods (6 papers), Protein purification and stability (5 papers) and HIV/AIDS drug development and treatment (5 papers). Linzhi Chen is often cited by papers focused on Biosimilars and Bioanalytical Methods (6 papers), Protein purification and stability (5 papers) and HIV/AIDS drug development and treatment (5 papers). Linzhi Chen collaborates with scholars based in United States, China and Germany. Linzhi Chen's co-authors include Xilin Lu, Huanjun Jiang, Bo Fu, Ying Zhou, Zhihua Huang, Yan‐Ping Mao, Diane Ramsden, Daniel Bischoff, Simone Schadt and Yongmei Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Antimicrobial Agents and Chemotherapy and Lab on a Chip.

In The Last Decade

Linzhi Chen

31 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linzhi Chen United States 13 127 99 64 55 50 33 352
Jiasheng Yang China 9 88 0.7× 90 0.9× 68 1.1× 10 0.2× 51 1.0× 26 314
Yongxing Chen China 10 43 0.3× 87 0.9× 12 0.2× 21 0.4× 9 0.2× 24 295
Kevin Lamote Belgium 14 71 0.6× 100 1.0× 3 0.0× 9 0.2× 28 0.6× 34 582
Zhu Wu China 9 33 0.3× 23 0.2× 31 0.5× 25 0.5× 34 265
SD Kim South Korea 10 11 0.1× 55 0.6× 6 0.1× 9 0.2× 4 0.1× 16 324
Martin Li Netherlands 7 35 0.3× 73 0.7× 3 0.0× 5 0.1× 13 0.3× 13 714
Julien Lambert France 8 23 0.2× 26 0.3× 5 0.1× 18 0.3× 6 0.1× 16 267
Zhanwei Zhao China 13 42 0.3× 84 0.8× 2 0.0× 24 0.4× 6 0.1× 35 554
Fan Wang China 9 9 0.1× 45 0.5× 7 0.1× 13 0.2× 15 0.3× 62 281

Countries citing papers authored by Linzhi Chen

Since Specialization
Citations

This map shows the geographic impact of Linzhi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linzhi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linzhi Chen more than expected).

Fields of papers citing papers by Linzhi Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linzhi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linzhi Chen. The network helps show where Linzhi Chen may publish in the future.

Co-authorship network of co-authors of Linzhi Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Linzhi Chen. A scholar is included among the top collaborators of Linzhi Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linzhi Chen. Linzhi Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Chengcheng, et al.. (2025). Burden of esophageal cancer in global, regional and national regions from 1990 to 2021 and its projection until 2050: results from the GBD study 2021. Frontiers in Oncology. 14. 1518567–1518567. 2 indexed citations
2.
Dong, Yixiao, Xuechun Wang, Wang Zhang, et al.. (2025). In situ tailored confining microenvironment for lung cancer spheroids. Materials Today Bio. 31. 101602–101602. 2 indexed citations
3.
4.
Chen, Linzhi, et al.. (2024). A Comprehensive Immunocapture-LC-MS/MS Bioanalytical Approach in Support of a Biotherapeutic Ocular PK Study. Pharmaceuticals. 17(2). 193–193. 2 indexed citations
6.
Li, Xiaomin, et al.. (2023). Effects of online-offline integrated death education on patients with advanced cancer: A before-and-after study. European Journal of Oncology Nursing. 67. 102433–102433. 4 indexed citations
7.
Jiang, Youhong, Qian Zhang, Linzhi Chen, et al.. (2023). On-chip gas reaction nanolab forin situTEM observation. Lab on a Chip. 23(17). 3768–3777. 3 indexed citations
8.
Zhou, Shiyuan, Kaige Liu, Linzhi Chen, et al.. (2023). Perspective of operando/in situ scanning electron microscope in rechargeable batteries. Current Opinion in Electrochemistry. 41. 101374–101374. 13 indexed citations
10.
Fuchs, Holger, Linzhi Chen, Sarah Löw, & Hongbin Yu. (2021). Ocular and systemic pharmacokinetics of BI-X, a nanobody targeting VEGF and Ang-2, after intravitreal dosing in cynomolgus monkeys – Evidence for half-life extension by albumin. Experimental Eye Research. 205. 108486–108486. 12 indexed citations
11.
Chen, Linzhi, et al.. (2016). Detection of cynomolgus monkey anti-protein XYZ antibody using immunocapture-LC/MS. SHILAP Revista de lepidopterología. 2(4). 117–128. 7 indexed citations
12.
Chen, Linzhi, Arvid Jungnik, Yan‐Ping Mao, et al.. (2014). Biotransformation and mass balance of the SGLT2 inhibitor empagliflozin in healthy volunteers. Xenobiotica. 45(6). 520–529. 24 indexed citations
13.
Chen, Linzhi, et al.. (2014). Biotransformation and mass balance of faldaprevir, a hepatitis C NS3/NS4 protease inhibitor in rats. Xenobiotica. 44(11). 1014–1025. 2 indexed citations
14.
Chen, Linzhi, Peter W. Rose, Yan‐Ping Mao, et al.. (2014). Mass Balance and Metabolite Profiling of Steady-State Faldaprevir, a Hepatitis C Virus NS3/4 Protease Inhibitor, in Healthy Male Subjects. Antimicrobial Agents and Chemotherapy. 58(4). 2369–2376. 8 indexed citations
15.
Chen, Linzhi, et al.. (2014). Mass Balance, Metabolite Profile, and In Vitro-In Vivo Comparison of Clearance Pathways of Deleobuvir, a Hepatitis C Virus Polymerase Inhibitor. Antimicrobial Agents and Chemotherapy. 59(1). 25–37. 10 indexed citations
16.
17.
Jiang, Huanjun, Xilin Lu, & Linzhi Chen. (2012). Seismic Fragility Assessment of RC Moment-Resisting Frames Designed According to the Current Chinese Seismic Design Code. Journal of Asian Architecture and Building Engineering. 11(1). 153–160. 23 indexed citations
18.
Lu, Xilin, Linzhi Chen, Ying Zhou, & Zhihua Huang. (2008). Shaking table model tests on a complex high‐rise building with two towers of different height connected by trusses. The Structural Design of Tall and Special Buildings. 18(7). 765–788. 35 indexed citations
19.
Macha, Sreeraj, et al.. (2007). Biotransformation and mass balance of tipranavir, a nonpeptidic protease inhibitor, when co-administered with ritonavir in Sprague-Dawley rats. Journal of Pharmacy and Pharmacology. 59(9). 1223–1233. 2 indexed citations
20.
Harrison, Lester I., et al.. (2002). Pharmacokinetic comparison of beclomethasone dipropionate extrafine aerosol from two inhaler devices in children with asthma. European Journal of Clinical Pharmacology. 58(3). 191–195. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026